LABD vs. GGLL
LABD (Direxion Daily S&P Biotech Bear 3x Shares) and GGLL (Direxion Daily GOOGL Bull 2X Shares) are both Leveraged Equities funds from Direxion - LABD tracks the S&P Biotechnology Select Industry Index (-300%) while GGLL tracks the Alphabet Inc. Class A (200%). Both are passively managed. Over the past 3 years, LABD returned -49.85%/yr vs 65.97%/yr for GGLL. At a correlation of -0.31, they often move in opposite directions. LABD charges 1.06%/yr vs 1.05%/yr for GGLL.
Performance
LABD vs. GGLL - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, LABD achieves a -29.83% return, which is significantly lower than GGLL's 22.24% return.
LABD
- 1D
- -4.73%
- 1M
- 4.70%
- YTD
- -29.83%
- 6M
- -31.22%
- 1Y
- -80.27%
- 3Y*
- -49.85%
- 5Y*
- -41.45%
- 10Y*
- -56.11%
GGLL
- 1D
- -1.40%
- 1M
- -13.22%
- YTD
- 22.24%
- 6M
- 15.91%
- 1Y
- 293.20%
- 3Y*
- 65.97%
- 5Y*
- —
- 10Y*
- —
LABD vs. GGLL - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
LABD Direxion Daily S&P Biotech Bear 3x Shares | -29.83% | -70.07% | -21.43% | -41.77% | -17.68% |
GGLL Direxion Daily GOOGL Bull 2X Shares | 22.24% | 123.07% | 48.88% | 81.20% | -30.35% |
Correlation
The correlation between LABD and GGLL is -0.31, meaning they tend to move in opposite directions. This is especially valuable for risk management - when one declines, the other has historically tended to hold steady or rise.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | -0.31 |
Correlation (3Y) Calculated over the trailing 3-year period | -0.29 |
Correlation (All Time) Calculated using the full available price history since Sep 8, 2022 | -0.31 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
LABD vs. GGLL — Risk / Return Rank
LABD
GGLL
LABD vs. GGLL - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Direxion Daily S&P Biotech Bear 3x Shares (LABD) and Direxion Daily GOOGL Bull 2X Shares (GGLL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| LABD | GGLL | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -6.13 | ||
| Sortino ratioReturn per unit of downside risk | -7.18 | ||
| Omega ratioGain probability vs. loss probability | 0.75 | 1.60 | -0.85 |
| Calmar ratioReturn relative to maximum drawdown | -0.97 | 7.69 | -8.66 |
| Martin ratioReturn relative to average drawdown | -1.31 | 26.53 | -27.83 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| LABD | GGLL | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -1.06 | 5.07 | -6.13 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.43 | — | — |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | -0.59 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.54 | 0.99 | -1.53 |
Drawdowns
LABD vs. GGLL - Drawdown Comparison
The maximum LABD drawdown since its inception was -99.99%, which is greater than GGLL's maximum drawdown of -52.81%. Use the drawdown chart below to compare losses from any high point for LABD and GGLL.
Loading charts...
Drawdown Indicators
| LABD | GGLL | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.99% | -52.81% | -47.18% |
Max Drawdown (1Y)Largest decline over 1 year | -83.21% | -38.39% | -44.82% |
Max Drawdown (3Y)Largest decline over 3 years | -95.31% | -52.81% | -42.50% |
Max Drawdown (5Y)Largest decline over 5 years | -98.24% | — | — |
Max Drawdown (10Y)Largest decline over 10 years | -99.98% | — | — |
Current DrawdownCurrent decline from peak | -99.99% | -21.02% | -78.97% |
Average DrawdownAverage peak-to-trough decline | -90.92% | -15.17% | -75.75% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 61.36% | 11.11% | +50.25% |
Volatility
LABD vs. GGLL - Volatility Comparison
Direxion Daily S&P Biotech Bear 3x Shares (LABD) has a higher volatility of 27.46% compared to Direxion Daily GOOGL Bull 2X Shares (GGLL) at 16.60%. This indicates that LABD's price experiences larger fluctuations and is considered to be riskier than GGLL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| LABD | GGLL | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 27.46% | 16.60% | +10.86% |
Volatility (6M)Calculated over the trailing 6-month period | 61.67% | 40.70% | +20.97% |
Volatility (1Y)Calculated over the trailing 1-year period | 75.77% | 58.40% | +17.37% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 96.26% | 56.03% | +40.23% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 95.93% | 56.03% | +39.90% |
LABD vs. GGLL - Expense Ratio Comparison
LABD has a 1.06% expense ratio, which is higher than GGLL's 1.05% expense ratio.
Dividends
LABD vs. GGLL - Dividend Comparison
LABD's dividend yield for the trailing twelve months is around 6.45%, more than GGLL's 3.73% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
GGLL Direxion Daily GOOGL Bull 2X Shares | 3.73% | 4.16% | 3.29% | 2.05% | 0.59% | 0.00% | 0.00% | 0.00% | 0.00% |
LABD Direxion Daily S&P Biotech Bear 3x Shares | 6.45% | 6.67% | 4.68% | 6.13% | 0.53% | 0.00% | 3.94% | 1.75% | 0.81% |
Frequently Asked Questions
LABD and GGLL have a correlation of -0.31, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
LABD has higher volatility (27.46%) compared to GGLL (16.60%). In terms of maximum drawdown, LABD dropped -99.99% vs GGLL's -52.81%.
On 3-year performance, GGLL leads with 65.97% vs -49.85% for LABD. On fees, GGLL is cheaper at 1.05% per year. On volatility, GGLL has been the lower-risk option at 16.60%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 3-year period, GGLL has performed better with a 65.97% return vs -49.85%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
GGLL is cheaper with a 1.05% expense ratio, compared with 1.06% for LABD.
LABD has the higher dividend yield at 6.45%, compared with 3.73% for GGLL.
LABD tracks S&P Biotechnology Select Industry Index (-300%), while GGLL tracks Alphabet Inc. Class A (200%). Their fees differ too: 1.06% for LABD and 1.05% for GGLL.
GGLL currently has the higher Sharpe Ratio (5.07 vs -1.06), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for LABD and GGLL
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer